¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Unqualified visual loss, one eye"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cogwheel eye movement
    Åé´Ï¹ÙÄû´«¿îµ¿, °è´ÜÇü´«¿îµ¿
  • cat¡¯s eye reflex
    °í¾çÀÌ´«ºû¹Ý»ç
  • cat-eye syndrome
    °í¾çÀÌ´«ÁõÈıº
  • dry eye
    °Ç¼º¾È
  • dry eye syndrome
    °Ç¼º¾ÈÁõÈıº, ¾È±¸°ÇÁ¶Áõ
  • deviating eye
    »ç½Ã¾È, ÆíÀ§¾È
  • doll¡¯s eye reflex
    ÀÎÇü´«¹Ý»ç
  • doll¡¯s eye sign
    ÀÎÇü´«Â¡ÈÄ
  • dominant eye
    ¿ì¼¼¾È
  • eye
    ´«
  • eye bank
    ¾È±¸ÀºÇà, ´«ÀºÇà
  • eye dominance
    ´«¿ì¼¼, ¾È¿ì¼¼(¼º)
  • eye drop
    Á¡¾È¾à
  • eye glasses
    ¾È°æ
  • eye lotion
    Á¡¾È¾à
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • amaurotic cat¡¯s eye
    Èæ¾Ï½Ã°í¾çÀÌ´«
  • artificial eye
    ÀǾÈ, ÀÎÁ¶´«
  • bull¡¯s eye macrostomia
    Ç¥ÀûȲ¹Ý, ¼Ò´«¸ð¾çȲ¹Ý
  • bull¡¯s eye maculopathy
    Ç¥ÀûȲ¹Ýº´Áõ, ¼Ò´«¸ð¾çȲ¹Ýº´Áõ
  • bull¡¯s eye plot
    ¼Ò´«µµÇ¥, ¿ì¾ÈÇüµµ¸é
  • bull¡¯s eye sign
    Ȳ¼Ò´«Â¡ÈÄ
  • bull¡¯s-eye shape
    ¼Ò´«¸ð¾ç, °ú³á¸ð¾ç
  • eye bank
    ´«ÀºÇà
  • cross-eye
    (¢¡esotropia) ³»»ç½Ã
  • cat¡¯s eye reflex
    °í¾çÀÌ´«ºû¹Ý»ç
  • cogwheel eye movement
    Åé´Ï¹ÙÄû´«¿îµ¿, °è´ÜÇü´«¿îµ¿
  • deviating eye
    ÆíÀ§¾È, »ç½Ã¾È
  • doll¡¯s eye sign
    ÀÎÇü´«Â¡ÈÄ
  • dominant eye
    ¿ì¼¼¾È
  • dry eye
    ¸¶¸¥´«, ´«¸¶¸§Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • pink eye
    ºÐÈ«»ö´«, ÃæÇ÷¾È(õöúìäÑ)
  • pop eye
    Åü¹æ¿ïÁø´«, Ãâ¸ñ(õóÙÍ)
  • posterior chamber (of eye) ³ª camera p. bulbi
    ¾ÈÈĹæ(äÑý­Û®).
  • posterior chamber (of eye) ³ª camera p. bulbi
    ¾ÈÈĹæ(äÑý­Û®).
  • primary eye vesicle
    ÀÏÂ÷¾ÈÆ÷(¡­äÑøà).
  • primary position (of eye)
    Á¦ÀϾÈÀ§(ð¯ìéäÑêÈ)
  • primary position of the eye
    Á¦ÀϾÈÀ§(ð¯ìé äÑêÈ), Á¦ÀÏ´«À§Ä¡
  • rapid eye movement
    ½Å¼Ó¾È±¸¿îµ¿.
  • rapid eye movement=REM
    ±Þ¼Ó¾È±¸¿îµ¿
  • rapid eye movements
    ±Þ¼Ó¾È¿îµ¿
  • red eye
    »¡°£´«, ÃæÇ÷¾È
  • reduced eye
    »ý·«¾È(ßèå²äÑ).
  • rem ; rapid eye movement ; rem spleep
    ·½, ·½¼ö¸é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • discrimination loss
    ¾îÀ½ÆÇº°¼Õ½Ç
  • economic loss
    °æÁ¦Àû ¼Õ½Ç.
  • evaporation loss
    Áõ¹ß¼Õ½Ç(¡­áßã÷).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • gastrointestinal loss
  • hearing loss
    °¨°¢½Å°æ(¼º) ³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
  • hearing loss, audiometric
    û·Â¼Õ½Ç
  • hearing loss, central
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • hearing loss, conductive
    ÀüÀ½¼º ³­Ã», Àüµµ¼º ³­Ã»
  • hearing loss, congenital hereditary
    ¼±Ãµ(¼º) À¯Àü¼º ³­Ã»
  • hearing loss, familial pregressive
    °¡Á· ÁøÇà(¼º) ³­Ã»
  • hearing loss, functional
    ±â´É(¼º) ³­Ã»
  • hearing loss, idiopathic sudden
    Ư¹ß¼º µ¹¹ß(¼º)³­Ã»
  • hearing loss, mixed
    È¥ÇÕ(¼º) ³­Ã»
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
DO Doctor of Osteopathy (one of two fully recognized medical practioners in the US-the other being MD);...
FEV1, FEV1 forced expiratory volume in one second
FIV1 forced inspiratory volume in one second
GW gigaohm [one billion ohms]
grav I pregnancy one, primigravida
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
Ahl Age-related hearing loss
ABL Alveolar bone loss
BEV beam eye views
CES Cat Eye Syndrome
CLEM Conjugate Lateral Eye Movement
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • weight loss
    üÁß °¨¼Ò
    ´Ü½Ä, ½ÄÀÌÁ¶Àý, º´À¸·Î ÀÎÇØ ³ªÅ¸³ª¸ç, üÁö¹æÀÇ °¨¼Ò ¶Ç´Â À½½Ä¼·Ãë ºÎÁ·À¸·Î ÀÎÇÑ ¿µ¾ç°áÇÌ ½Ã¿¡ ³ªÅ¸³­´Ù.
  • appendages of eye
    ´« ºÎ¼Ó ±â°ü
  • blear eye
    ¾È°Ë¿¬¿°
    ´«²¨Ç®Å× ¿°Áõ
  • bull's eye shape
    Ȳ¼Ò ´«¾Ë ¸ð¾ç
  • bulls eye maculopathy
    Ç¥Àû Ȳ¹Ýº´Áõ, ¼Ò ´« ¸ð¾ç Ȳ¹Ýº´Áõ
  • coloboma of eye lid
    ´«²¨Ç® °á¼Õ, ¾È°Ë °á¼Õ
  • cross-eye
    »ç½Ã, ³»»ç½Ã
  • doll's eye reflex
    ÀÎÇüÀÇ ¾È ¹Ý»ç
    Á¶»ê¾ÆÀÇ ¸Ó¸®¸¦ ¿·À¸·Î µ¹¸®¸é ¾È±¸´Â ¹Ý´ëÂÊÀ¸·Î °°ÀÌ À̵¿ÇÑ ÈÄ ´Ù½Ã ¾È¿­ÀÇ Áß¾Ó¿¡ µ¹¾Æ¿À´Â ¹Ý»ç.
  • dolls eye sign
    ÀÎÇü ¾È ¡ÈÄ
  • dry eye
    ¾È±¸ °ÇÁ¶
  • drying of the eye
    ¾È±¸ °ÇÁ¶
  • equator of the eye
    ¾È±¸ Àûµµ
  • eye
    ¾È, ´«
    µ¿ÀǾî=oculus. ºûÀÇ Àڱؿ¡ ÀÇÇÏ¿© ¹°°ÇÀ» º¸°Ô µÇ´Â °¨°¢ ±â°ü. ½Ã°¢°èÀÇ °¡Àå Áß¿äÇÑ ºÎºÐÀ¸·Î, ¾È¿ÍÀÇ ¾ÕºÎºÐ¿¡ ÀÖÀ¸¸ç, °ÅÀÇ ±¸ÇüÀ» ÀÌ·é´Ù.
  • eye bank
    ¾È ÀºÇà, ´« ÀºÇà
  • eye change
    ¾È º¯È­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
visual Pertaining to vision or sight.
Origin: L. Visualis, from videre = to see
(18 Nov 1997)
visual acuity <microscopy> The ability to detect fine details or small distances with the eye. Visual acuity can vary substantially depending on the definition used and method of measurement chosen. Under favourable conditions, the resolution of the human eye or ability to distinguish the twoness of adjoining lines, is about I minute of arc while the threshold delectability, or the detection of misaligned steps in a line (which is also a form of visual acuity), can be as low as a fraction of a second of arc.
(05 Aug 1998)
visual agnosia The inability to recognise objects by sight; usually caused by bilateral parieto-occipital lesions.
Synonym: optic agnosia.
(05 Mar 2000)
visual angle The angle formed at the retina by the meeting of lines drawn from the periphery of the object seen.
(05 Mar 2000)
visual aphasia <neurology> Loss of the ability to understand printed words or sentences
(27 Sep 1997)
visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
visual axis The straight line extending from the object seen, through the centre of the pupil, to the macula lutea of the retina.
Synonym: line of vision.
(05 Mar 2000)
visual blackout See: amaurosis fugax.
(05 Mar 2000)
visual cortex Area of the occipital lobe concerned with vision.
(12 Dec 1998)
visual cycle The transformation of carotenoids involved in the bleaching and regeneration of the visual pigment.
(05 Mar 2000)
visual efficiency A rating used in computing compensation for industrial ocular injuries, incorporating measurements of central acuity, visual field, and ocular motility.
(05 Mar 2000)
visual evoked potential Voltage fluctuations that may be recorded from the occipital area of the scalp as the result of retinal stimulation by a light flashing at 1/4-second intervals; commonly summated and averaged by computer.
(05 Mar 2000)
visual extinction A condition in which individual stimuli are seen correctly, but when the nasal visual field of one eye and the temporal visual field of the fellow eye are stimulated simultaneously, one field is blind.
Synonym: visual extinction.
(05 Mar 2000)
visual field The area simultaneously visible to one eye without movement; often measured by means of a bowl perimeter located 330 mm from the eye.
(05 Mar 2000)
visual field test <ophthalmology> A test which measures the extent of visual field loss. This test may be performed by a number of methods including confrontation, tangent screen exam and automated perimetry.
Diseases that affect visual field include stroke, diabetes, hypertension, multiple sclerosis, glaucoma, hyperthyroidism, Jacob-Creutzfeldt disease and optic glioma.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • stand on one's head
    ¹°±¸³ª¹«¸¦ ¼­´Ù
  • ten to one
    ½ÊÁßÆÈ±¸
  • tie one's tie
    ³ØÅ¸À̸¦ ¸Å´Ù
  • to one's benefit
    ÀÌÀÍÀÌ µÇ´Â; À¯ÀÍÇÑ
  • to one's horror
    ¹«¼·°Ôµµ
  • to one's surprise
    ³î¶ø°Ôµµ
  • ~one thing,-another
    ~¿Í -Àº º°°³ÀÌ´Ù
  • Day one
    ÃÖÃÊÀÇ ³¯
  • Evil One
    ¸¶¿Õ
  • Formula One
    Æ÷¹Ä·¯ ¿ø(¹è±â·® 1500-3000 c.c.ÀÇ ¿£ÁøÀÌ ´Þ¸° °æÁÖÂ÷)
  • God's Eye
    ½ÅÀÇ ´«(Àܰ¡Áö·Î ¸¸µç ½ÊÀÚ°¡¿¡ »ö½ÇÀ» ±âÇÏÇÐÀû ¹«´Ì·Î °¨Àº °Í,¸ß½ÃÄÚ,¹Ì±¹ ³²¼­ºÎ¿¡¼­ Çà¿îÀÇ ºÎÀûÀ¸·Î ¾¸)
  • Holy One
    ¿¹¼ö±×¸®½ºµµ;±¸¼¼ÁÖ;õÁÖ
  • Human One
    »ç¶÷ÀÇ ¾Æµé;¿¹¼ö ±×¸®½ºµµ
  • Magic Eye
    (¶§·Î m~ e~) (¶óµð¿À ¼ö½Å±âÀÇ) µ¿Á¶ Áö½Ã¿ë Áø°ø°ü (»óÇ¥¸í)
  • apple of the eye
    ´«µ¿ÀÚ;±ÍÁßÇÑ °Í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á